Omnicell (OMCL)
(Real Time Quote from BATS)
$43.62 USD
-1.00 (-2.24%)
Updated Sep 23, 2024 11:56 AM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OMCL 43.62 -1.00(-2.24%)
Will OMCL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OMCL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OMCL
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Should You Continue to Retain OMCL Stock in Your Portfolio Now?
OMCL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy?
Omnicell (OMCL) Introduces Central Med Automation Service
Other News for OMCL
Omnicell’s Steady Growth and Hold Rating: A Cautious Outlook on Automation Services Expansion
Omnicell management to meet virtually with KeyBanc
Craig-Hallum Remains a Buy on Omnicell (OMCL)
Piper Sandler Remains a Buy on Omnicell (OMCL)
Omnicell price target raised by $11 at JPMorgan, here's why